In March 2025, the company introduced new options to get a immediate-to-customer offering of its Wegovy weight loss drug. The company proven a fresh pharmacy, identified as NovoCare, which would charge shoppers $499 monthly for entry to the drug, lower than half the cost of the drug through other pharmaceutical distribution networks.[fifty three]Ca